Focus: Immunome is an early-stage cancer immunotherapy biotech focused on solid malignancies and rare oncology indications. The company is headquartered in Exton, PA and operates at pre-revenue/clinical stage with a focused pipeline.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Cooling — net -7 jobs in 30d
13 added, 20 removed. Slower than typical.
Immunome offers high-growth potential and meaningful early-stage development work, but career security depends heavily on clinical trial success and undisclosed funding adequacy.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Immunome
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Immunome's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles